Markman Advisors
Patent Valuation, Monetization and Investments

Blog

Markman Advisors Patent Blog

by Zachary Silbersher

Posts tagged vacepa
Amarin: What does Amarin’s reply appellate brief say?

Amarin’s appeal of the district court’s decision invalidating the Marine patents is now fully briefed. Amarin’s reply brief is strong, but does it tip the odds in favor of Amarin prevailing on the appeal?

Read More
Markman AdvisorsAmarin Pharma, Amarin, $AMRN, AMRN, vacepa, Hikma, Dr. Reddy's, Federal Circuit, patent, hypertriglyceridemia, triglycerides, LDL-C, Dr. Bhatt, Bhatt, EPA, Epadel, Lovasa, Heinecke, Zachary Silbersher, Silbersher Comments